- Home
- KIM vs DGX Comparison
KIM vs DGX Comparison
Compare KIM & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KIM
- DGX
- Stock Information
- Founded
- KIM 1958
- DGX 1967
- Country
- KIM United States
- DGX United States
- Employees
- KIM N/A
- DGX N/A
- Industry
- KIM Real Estate Investment Trusts
- DGX Medical Specialities
- Sector
- KIM Real Estate
- DGX Health Care
- Exchange
- KIM Nasdaq
- DGX Nasdaq
- Market Cap
- KIM 16.1B
- DGX 17.5B
- IPO Year
- KIM 1991
- DGX 1996
- Fundamental
- Price
- KIM $24.88
- DGX $160.46
- Analyst Decision
- KIM Buy
- DGX Buy
- Analyst Count
- KIM 16
- DGX 13
- Target Price
- KIM $24.08
- DGX $163.38
- AVG Volume (30 Days)
- KIM 4.0M
- DGX 1.0M
- Earning Date
- KIM 10-31-2024
- DGX 10-22-2024
- Dividend Yield
- KIM 4.02%
- DGX 1.87%
- EPS Growth
- KIM N/A
- DGX 11.56
- EPS
- KIM 0.53
- DGX 7.44
- Revenue
- KIM $1,963,220,000.00
- DGX $9,539,000,000.00
- Revenue This Year
- KIM N/A
- DGX $7.33
- Revenue Next Year
- KIM $3.20
- DGX $8.69
- P/E Ratio
- KIM $47.03
- DGX $21.57
- Revenue Growth
- KIM 10.81
- DGX 2.60
- 52 Week Low
- KIM $17.57
- DGX $123.04
- 52 Week High
- KIM $25.19
- DGX $162.59
- Technical
- Relative Strength Index (RSI)
- KIM 60.81
- DGX 60.76
- Support Level
- KIM $23.67
- DGX $156.10
- Resistance Level
- KIM $25.19
- DGX $162.59
- Average True Range (ATR)
- KIM 0.48
- DGX 2.91
- MACD
- KIM 0.03
- DGX 0.37
- Stochastic Oscillator
- KIM 80.13
- DGX 79.72
About KIM Kimco Realty Corporation (HC)
One of the oldest real estate investment trusts in the United States, Kimco Realty owns interests in 569 shopping centers throughout major markets in the US, representing roughly 87 million square feet.
About DGX Quest Diagnostics Incorporated
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.